Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Sulfisoxazole
Cat. No.:
OB0225LY-0378
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Sulfisoxazole is a sulfonamide antibiotic with antimicrobial properties.
Synonym:
NU-445; 127-69-5; Sulphafurazole; Sulfisoxazol; Sulfafurazol; Sulfaisoxazole; Sulfofurazole; Gantrisin; Sulfisoxasole; Sulphaisoxazole; 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide; 3,4-Dimethylisoxazole-5-sulfanilamide; 3,4-Dimethyl-5-sulphanilamidoisoxazole
CAS No.:
127-69-5
Compound CID:
5344
Formula:
C11H13N3O3S
Formula Weight:
267.3
Specification
Relative Density:
1.411 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Sulfisoxazole can be used in microbiological studies to assess the effectiveness of antimicrobial drugs or play an important role in the development of anti-infective drugs.
Library Information
Targets:
Bacterial enzymes
Receptors:
DHPS; Endothelin receptor
Pathways:
GPCR/G protein; Autophagy; Microbiology/Virology
Plate Number:
AOCL-5
Plate Location:
h3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 187.06 mM
